AstraZeneca Stock Rises on Vaccine Approvals
Last Updated: December 30, 2020
AstraZeneca stock was trading higher in the US premarket today after its COVID-19 vaccine candidate got an emergency use approval from Britain. Indonesia has also placed an order for 50 million doses of its vaccine.
There has been a lot of positive development on the COVID-19 vaccine front. India is also expected to soon approve of the AstraZeneca vaccine. It does not need the kind of low storage temperatures that Pfizer and Moderna’s vaccine requires and would suit India’s tropical climate.
The US falls short of vaccination target
The US has already approved the emergency use of Moderna’s and Pfizer’s COVID-19 vaccine candidates and started the inoculation process. However, the current run rate of inoculating Americans is way short of what the country was aiming for. The drive has been named Operation Warp Speed and aims to deliver 300 million doses.
Corona in Deutschland: Aktuelle News zum Virus
schwaebische.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from schwaebische.de Daily Mail and Mail on Sunday newspapers.
Impfstoff von AstraZeneca in Großbritannien zugelassen - Panorama
dtoday.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dtoday.de Daily Mail and Mail on Sunday newspapers.
Impfstoff von AstraZeneca in Großbritannien zugelassen - Nachrichten
dtoday.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dtoday.de Daily Mail and Mail on Sunday newspapers.